Acetazolamide for Treatment Resistant Schizophrenia (NCT04887792)

🧪 Interventions in This Study

• Acetazolamide (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• University of Pittsburgh — Pittsburgh, Pennsylvania
• St John's Medical College Hospital — Bangalore,

📞 Contact the Study Coordinator

Phone: (412) 246-6356

Email: vishwajitNL@upmc.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Schizophrenia

• Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
• Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
• Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
• Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
• Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
• Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia

Explore by condition: All Schizophrenia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.